Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received May 1, 2020
- Accepted June 24, 2020
- Published online August 6, 2020.
Copyright & Usage
Copyright ©ERS 2020
Author Information
- Silke Feuerriegel1,2,
- Thomas A. Kohl1,2,
- Christian Utpatel1,2,
- Sönke Andres3,
- Florian P. Maurer3,4,
- Jan Heyckendorf2,5,6,
- Agathe Jouet7,
- Nelly Badalato7,
- Lynda Foray8,
- Rashidatu Fouad Kamara8,
- Osman S. Conteh9,
- Philip Supply10,11 and
- Stefan Niemann1,2,11⇑
- 1Molecular and Experimental Mycobacteriology, Research Centre Borstel, Borstel, Germany
- 2German Centre for Infection Research (DZIF), Partner site Hamburg-Lübeck-Borstel, Borstel, Germany
- 3National and WHO Supranational Reference Centre for Mycobacteria, Research Centre Borstel, Borstel, Germany
- 4Institute of Medical Microbiology, Virology and Hygiene, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany
- 5Clinical Infectious Diseases, Research Centre Borstel, Borstel, Germany
- 6International Health/Infectious Diseases, University of Lübeck, Lübeck, Germany
- 7Genoscreen, Campus de l'Institut Pasteur de Lille, Lille, France
- 8National Tuberculosis Control Programme, Ministry of Health and Sanitation, Freetown, Sierra Leone
- 9National Reference Laboratory, Lakka Government Hospital, Freetown, Sierra Leone
- 10Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 9017 - CIIL - Center for Infection and Immunity of Lille, Lille, France
- 11Philip Supply and Stefan Niemann contributed equally to the study
- Stefan Niemann, Molecular and Experimental Mycobacteriology, Research Centre Borstel, 23845 Borstel, Germany. E-mail: sniemann{at}fz-borstel.de
Funding
European Commission
FP7- 278864Deutsches Zentrum für Infektionsforschung
Joachim Herz Stiftung
Leibniz Science Campus Evolutionary Medicine of the LUNG
Deutsche Forschungsgemeinschaft
Precision Medicine in Chronic Inflammation EXC 216
Article usage
Altmetrics
Vol 56 Issue 3
Table of Contents
Rapid genomic first- and second-line drug resistance prediction from clinical Mycobacterium tuberculosis specimens using Deeplex®-MycTB
